Skip to main content
. 2021 Apr 16;6(2):111–119. doi: 10.1089/trgh.2020.0029

Table 1.

Demographics of Transgender and Cisgender Participants

 
Assigned female at birth
Assigned male at birth
  Transgender males (n=9) Cisgender females (n=14) Transgender females (n=8) Cisgender males (n=17)
Age (years) 13.8±1.7 13.9±1.7 13.7±1.2 13.9±0.9
Age at initiation of GnRHa (years) 12.1±1.9 12.8±1.3
GnRHa duration (months) 20.9±19.8 11.3±7
Race
 White 6 (67) 10 (71) 7 (88) 13 (76)
 Asian 0 (0) 1 (7) 0 (0) 1 (6)
 African American 1 (11) 3 (21) 0 (0) 1 (6)
 More than one race 1 (11) 0 (0) 1 (12) 0 (0)
 Unknown/not reported 1 (11) 0 (0) 0 (0) 2 (12)
Ethnicity
 Hispanic/Latino 4 (44) 4 (29) 4 (50) 3 (18)
 Not Hispanic/Latino 5 (56) 9 (64) 4 (50) 13 (76)
 Unknown/not reported 0 (0) 1 (7) 0 (0) 1 (6)
Depression 2 (22) 3 (38)
Anxiety 1 (11) 1 (12)
Pubic hair Tanner stage
 1 1 (11) 1 (7) 1 (12) 1 (6)
 2 0 (0) 0 (0) 3 (38) 5 (29)
 3 1 (11) 2 (14) 0 (0) 3 (18)
 4 3 (33) 4 (29) 1 (12) 2 (12)
 5 2 (22) 1 (7) 1 (12) 1 (6)
 Missing 2 (22) 6 (43) 2 (25) 5 (29)
Breast/testicular Tanner stage
 2 1 (11) 1 (7) 5 (63) 7 (41)
 3 3 (33) 1 (7) 0 (0) 3 (18)
 4 2 (22) 3 (21) 1 (12) 3 (18)
 5 2 (22) 9 (64) 2 (25) 4 (24)
 Missing 1 (11) 0 (0) 0 (0) 0 (0)
Family historya
 Hypertension 5 (63) 6 (75) 5 (63) 9 (75)
 Hypercholesterolemia 5 (63) 7 (88) 3 (38) 8 (67)
 Type 2 diabetes 4 (50) 7 (64) 1 (13) 4 (33)

Values above represent the entire cohort used and are either presented as mean±SD or n (%).

a

Family history is given out of total number of reported values (nonmissing). For transgender males, family history was missing for one participant. For cisgender females, family history was missing for hypertension (n=6), hypercholesterolemia (n=6), type 2 diabetes (n=3). Family history was not missing for any transgender female and was missing for 5 cisgender males (all conditions).

GnRHa, gonadotropin-releasing hormone agonist; SD, standard deviation.